Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine in Refractory Convulsive Status Epilepticus in Children
NCT02431663Phase 3Terminated
- Sponsor
- Meyer Children's Hospital IRCCS
- Start
- Apr 2015
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketamine in status epilepticus (SE), sponsored by Meyer Children's Hospital IRCCS. Started Apr 2015; status: terminated.
02
Drugs
ketamine
03
Conditions
status epilepticus (SE)
Beyond the preview
Go deeper on NCT02431663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02431663.